跳至主要内容
临床试验/CTRI/2025/06/088499
CTRI/2025/06/088499尚未招募2 期

A Randomised Clinical Trial To Evaluate The Efficacy Of Shigru Beejadi Ghruta And M D Forte Taila Nasya In The Management Of Anovulation In Polycystic Ovarian Disease PCOD

Dr Pawar Sankirna Appu1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年6月26日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
4.Pain during menses

研究概览

简要总结

Polycystic ovarian syndrome is a common gynecological condition that affects women of reproductive age with its increasing incidence due to sedentary lifestyle, excess intake of junk food and stress.

Incidence of 8-13% in women of reproductive age and upto 70% of cases are undiagnosed1. Anovulation is the cause of infertility in about a third of couples attending infertility clinics and PCOS accounts for 90% of such cases

Women with PCOS have irregular menstrual cycle, androgen excess, insulin resistance, anovulation, hirsutism, acne and infertility.

Modern management of PCOS is targeted to weight reduction in obese, hormonal pills and invasive techniques, which gives only symptomatic relief.

We find these symptoms of PCOS in Ayurveda as Pushpaghni Jataharini, Artavakshaya, Nastartava and Granthibhuta Artava

In this study, polycystic ovarian disease (PCOD) will be considered as main emphasis will be given on treatment for ovulation and other symptoms of PCOS will not be included.

Shigru Beejadi Ghruta will be formed by combination of Shigru Beeja, Jatamamsi, Trikatu and Nagakesara.This combination of drugs may be proven beneficial in providing relief to multiple symptoms present in PCOS

Mundi Dhanyaka Taila which is currently available as M.D Forte Taila from Amruthakala Ayurveda  is proved to be beneficial in treating anovulation and other symptoms of PCOS.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
21.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • 1.Married women 2.Irregular menses 3.Hyperandrogenism 4.Polycystic ovaries.

排除标准

  • Patients with primary amenorrhea.
  • Endocrinological disorders like Diabetes Mellitus, Thyroid abnormalities, Congenital Adrenal Hyperplasia and Hyperprolactinemia.
  • Chronic systemic diseases which can interfere with the treatment.
  • Any malignancy of Breast or cervical or ovarian origin.
  • 5.Patients on oral contraceptive pills, IUCD, injectable contraceptives.
  • USG showing Congenital or Acquired Anatomical defects, Pelvic pathology.
  • 7.Pregnant and lactating mothers.
  • 8.Those contraindicated for Pratimarsha Nasya.

结局指标

主要结局

4.Pain during menses

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

Objective parameters

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

1.Hirsutism score

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

2.GAGS score scale

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

3.ANSC scoring chart

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

5.Vas Score

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

4.BMI and Weight Reduction, and WHR.

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

6.WaLIDD score

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

Assesed based on subjective and objective parameters

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

Subjective Parameters

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

Quantity of menses

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

2.Duration of bleeding

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

3.Interval between the menstrual cycles

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

7.USG of pelvis for ovarian follicular study, endometrial thickness and to assess ovulation BT once and at the end of the study (3rd M).

时间窗: Follicular study will be done for 3 months to check ovulation | and final assessment will be done on 3rd month of study

次要结局

未报告次要终点

研究者

发起方
Dr Pawar Sankirna Appu
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Pawar Sankirna Appu

Alvas Ayurveda Medical College,Moodbidrie

研究点 (1)

Loading locations...

相似试验